My major goal in writing this short is to raise awareness among my peers about the possible advantages of using technology to improve one’s health. Therefore, nurses are the key target demographic. In order to come up with practical responses for our patients, we plan to provide them with a briefing document.
I stumbled upon a technology education programme targeted at promoting good habits among people with heart failure while conducting some internet research (HF). It was decided that Motivate4Change would be the topic of discussion in this briefing (Oosterom-Calo et al., 2014). Heart failure patients are encouraged to participate in physical activity via the use of this technology-based patient education programme. Patients with heart failure in hospitals and nurses engaging in patient education programmes both make use of this tool. As a result of the counselling offered by Motivate4Change, patients are more likely to report an increase in their medication adherence. To inspire and guide the construction of this programme, the intervention mapping approach for health promotion programmes was employed. Health promotion programmes may be developed using the intervention mapping method (Oosterom-Calo et al., 2014, p. e32).
Its key goals are to educate heart failure patients in the hospital on medication adherence and physical exercise and to encourage them to continue these practices when they are released from the hospital. (Oosterom-Calo et al., 2014). The program’s framework includes an overview, medication adherence, and physical exercise. Each module consists of an introduction, essential statements for patients to remember, a video with data on physical activity and medication adherence, and evaluations and feedback. An introduction, essential words for patients to remember and stats on physical activity and medication compliance are included in the first portion of each session. Multiple choice questions are shown on a touchscreen for patients to answer in the medication adherence module.
In addition, a continuous assessment of medication adherence challenges is conducted. The estimate of pharmaceutical assumptions is completed at the end of the study (Oosterom-Calo et al., 2014). Each stage is linked to the previous ones. As a consequence of their answers to the evaluation questions, patients will get a notification.
When it comes to Motivate 4Change, all these processes are included, including the evaluation of requirements and the establishment of performance objectives as well as the selection of methods and behavioural change tactics (Oosterom-Calo, te Velde, Student, & Brug, 2015). There is presently no data on the programme since it is so new. On the other hand, techniques that have been tested in previous comparable projects seem promising.
The life expectancy of people with severe mental illnesses (SMIs) is much lower than that of the general population. We take a look at how digital technology could be able to help solve this massive public health issue. It is part of our clinical assessment to explore how digital technology might help lower the risk of excess mortality at the person, health care system, and societal determinants of health levels. If SMD sufferers utilise digital technology, they may be able to prevent physical health issues, which is extremely beneficial. It’s important to keep in mind that little is known about how these technologies may be used to reduce the likelihood of premature mortality. There is a lot of potential in individual-level digital therapy for the treatment of mental health symptoms, the promotion of healthy behaviours, and the treatment of drug use disorders. Using digital interventions in the healthcare sector may improve patient care coordination, physician training, health indices screening and monitoring, and collaborative decision-making at the system level. Technology may make it easier for people with disabilities to participate in self-management and health promotion programmes, as well as help employment programmes. There has never been a better time to have SMDs. Using early evidence to support the creation, testing and implementation of successful digital activities to reduce the risk factors that lead to a lower life expectancy are essential. The scalability and long-term viability of innovative digital techniques can only be possible if more people use them. Future research challenges and possibilities include integrating users in the creation and testing of digital therapies, taking into account risks and harms, and thoroughly analysing efficacy and cost.